The Korean Health and Welfare Ministry announced that by 2020, the government will spend KRW 146 billion ($126 million) to subsidize drug firms. The funding aims to make Korea the seventh-largest drug industry by increasing its share of the export market from 0.2% to 5.4%. Under the plan, 10 new drugs will be produced by […]
India’s INR 90,000 crore ($19.0 billion = INR 45.17 = $1) generic drug industry and growth of its pharmaceutical market over the past few years has made it an ideal place for foreign drug firms to invest. However, recent compliance and quality issues at Indian firms have made global drug companies wary of future acquisitions […]
To increase sluggish returns on investment, pharmaceutical and biotechnology firms are relying more on CROs, according to a new report from the Economist Intelligence Unit (EIU). In the last two years, pharmaceutical and biotech firms have established 22 major partnerships with CROs, which now account for 40% of discovery and development (D&D). In September 2011, […]
The percentage of NIH research grant applications that were funded fell 3% to a record low of 18% in fiscal 2011. The decline is mainly due to the funding of continuing multiyear R01 grants. Funding such grants cost the NIH an additional $189 million and accounted for 78% of available grant money. Another factor was […]
According to the Industrial Research Institute’s (IRI) 28th annual “R&D Trends Forecast,” 53% of respondents plan to spend the same amount on R&D in 2012 as last year. The IRI surveyed R&D managers at 104 firms in multiple industries in July and August 2011. R&D budget increases of 2.5% to 5% are expected by 22% […]
US equity markets recorded positive gains in January due to improved consumer sentiment, strong manufacturing data and the Fed’s announcement that it will maintain exceptionally low rates through late 2014. In addition, China reported better-than-expected fourth-quarter growth, which climbed 8.9%. As such, the Dow Jones Industrial Average, S&P 500 and NASDAQ climbed 3.4%, 4.4% and […]
Washington, DC 1/25/12—Affymetrix announced in an SEC filing that it has agreed to settle a class-action suit brought by Tang Capital Partners, in which Tang alleged Affymetrix had violated the terms of its Senor Convertible Notes (see IBO 12/31/11). As part of the settlement, Affymetrix will commence a tender offer within two weeks to repurchase […]
Jena, Germany 1/11/12—CyBio, a subsidiary of Analytik Jena, has announced that it will propose at its shareholders meeting on April 27 to authorize the Management Board to apply to withdraw its listing from the Frankfurt Stock Exchange’s Regulated Market. Analytik Jena will make an offer to minority shareholders to purchase their shares in accordance with […]
Carlsbad, CA 1/24/12—Life Technologies has acquired Matrix MicroScience, a UK-based manufacturer of large-volume, automated sample preparation systems and consumables for food safety testing. The company’s products include the PATHATRIX AUTO system for isolating and concentrating target bacteria in food samples at high volumes. “This acquisition provides all the benefits we were looking for to address […]
Karlsruhe, Germany 1/26/12—Bruker AXS GmbH has acquired the assets of Hecus X-ray Systems, a maker of small-angle X-ray scattering systems (SAXS) based on advanced Kratky technology, for an undisclosed amount. The acquisition adds the MICROcaliX product line to Bruker AXS’s product line. “I am convinced that our expanded SAXS product portfolio that now includes our […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
